UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
VTVT
vTv Therapeutics Inc.
There isn't enough reported data to score VTVT yet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
VTVT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
VTVT's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | โ |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | โ |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
VTVT PE Valuation
VTVT has no meaningful PE right now: it lost money over the past year.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
VTVT Forward outlook
There aren't enough analyst estimates for VTVT to show an outlook.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over VTVT on earnings quality, reporting a profit while its opponent remains loss making.
VTVT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.11 | +$3.09 |
| Q1 2026 | $0.02 | +$3.11 |
| Q4 2025 | -$3.62 | -$0.13 |
| Q3 2025 | -$3.40 | +$1.13 |
| Q2 2025 | -$3.20 | +$3.72 |
| Q1 2025 | -$3.09 | +$5.78 |
| Q4 2024 | -$3.49 | +$6.42 |
| Q3 2024 | -$4.53 | +$6.04 |
VTVT lost $0.11 per share over the past year, a smaller loss than the year before.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over VTVT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
VTVT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2022 | $9K | 0% |
| Q2 2022 | $9K | 0% |
| Q1 2022 | $2M | +103% |
| Q4 2021 | $9K | -100% |
| Q3 2021 | $3M | +42757% |
| Q1 2021 | $987K | +12238% |
| Q4 2020 | $6.4M | +91314% |
VTVT's revenue is growing: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | 63% | N/A |
| Q4 2024 | -28776% | N/A |
| Q1 2024 | -563% | N/A |
| Q4 2022 | -70478% | +52956 points |
| Q2 2022 | -44744% | +7144 points |
| Q1 2022 | -324% | +110 points |
| Q4 2021 | -123433% | -123462 points |
| Q3 2021 | -53% | +40404 points |
VTVT's operating margin was 63% last quarter, up 44808 points from the same quarter a year ago, near the top of its range since 2019.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over VTVT on cash generation, producing positive trailing cash flow while its opponent burns cash.
VTVT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10.2M | -$5M |
| Q2 2026 | -$11.4M | -$6.3M |
| Q1 2026 | $9.2M | +$14.8M |
| Q4 2025 | -$9.3M | -$4.4M |
| Q3 2025 | -$5.2M | +$1.2M |
| Q2 2025 | -$5.1M | +$1.6M |
| Q1 2025 | -$5.7M | +$1.6M |
| Q4 2024 | -$4.8M | -$1.9M |
VTVT has burned cash in almost every quarter: โ$22M over the past year, against โ$21M the year before.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
VTVT Net Leverage
VTVT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
VTVT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 3.6 | Oversold |
VTVT's weekly RSI is 31 (neutral) and its Stochastic is 4 (oversold).
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH has the edge over VTVT on valuation relative to its sector.
VTVT PE vs Healthcare Sector
| Metric | VTVT | Sector median | Relative |
|---|---|---|---|
| PE | 1,559x | 26x | 5,931% above |
| PE % | 19 | 29 | 10 pts below |
VTVT has no meaningful PE right now: it lost money over the past year.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over VTVT on trend strength, trading above more of its moving averages.
VTVT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.4 | 22% below |
| 20 week MA | $30.2 | 31% below |
| 50 week MA | $33.0 | 37% below |
| 100 week MA | $25.8 | 20% below |
| 200 week MA | $23.5 | 12% below |
VTVT is in a downtrend: it's below all five of its weekly moving averages, and 12% below its 200-week average.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over VTVT on returns for 2026, with the stronger performance.
VTVT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $71.6 | $82.0 | +15% |
| 2021 | $82.0 | $43.2 | -47% |
| 2022 | $43.2 | $27.2 | -37% |
| 2023 | $27.2 | $11.5 | -58% |
| 2024 | $11.5 | $13.2 | +15% |
| 2025 | $13.2 | $37.9 | +187% |
| 2026 YTD | $37.9 | $20.7 | -45% |
VTVT's yearly returns have swung widely, from +187% in 2025 to โ58% in 2023. It's down 45% so far in 2026.